0001140361-24-001728.txt : 20240110 0001140361-24-001728.hdr.sgml : 20240110 20240110160536 ACCESSION NUMBER: 0001140361-24-001728 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240110 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240110 DATE AS OF CHANGE: 20240110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANUWAVE Health, Inc. CENTRAL INDEX KEY: 0001417663 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 201176000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52985 FILM NUMBER: 24526619 BUSINESS ADDRESS: STREET 1: 3360 MARTIN FARM RD STREET 2: SUITE 100 CITY: SUWANEE STATE: GA ZIP: 30024 BUSINESS PHONE: 770-419-7525 MAIL ADDRESS: STREET 1: 3360 MARTIN FARM RD STREET 2: SUITE 100 CITY: SUWANEE STATE: GA ZIP: 30024 FORMER COMPANY: FORMER CONFORMED NAME: RUB MUSIC ENTERPRISES, INC. DATE OF NAME CHANGE: 20071106 8-K 1 ef20018511_8k.htm 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
January 10, 2024

SANUWAVE Health, Inc.
(Exact name of registrant as specified in its charter)

Nevada
000-52985
20-1176000
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

11495 Valley View Road, Eden Prairie, Minnesota
  
55344
(Address of principal executive offices)
  
(Zip Code)

Registrant’s telephone number, including area code
(770) 419-7525

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
N/A
N/A
N/A

Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02
Results of Operations and Financial Condition.

On January 10, 2024, SANUWAVE Health, Inc., a Nevada corporation (the “Company”), issued a press release announcing certain preliminary financial results for the quarter and fiscal year ended December 31, 2023. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01
Financial Statements and Exhibits.

(d)
Exhibits.

Exhibit No.
  
Description
     
 
Press release dated January 10, 2024
104
  
Cover Page Interactive Data File––the cover page XBRL tags are embedded within the Inline XBRL document.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
SANUWAVE HEALTH, INC.
     
Dated: January 10, 2024
By:
/s/ Toni Rinow
 
Name:
Toni Rinow
 
Title:
Chief Financial Officer


EX-99.1 2 ef20018511_ex99-1.htm EXHIBIT 99.1
Exhibit 99.1


SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023.  This represents a new quarterly revenue record for the Company.
 
Q4 2023 revenue increased 20% to 24% over Q4 2022 and in excess of 30% versus the third quarter of 2023.
 
Preliminary FY 2023 revenue range was $20.0 million to $20.2 million, an increase of 19% to 20% year over year. This represents record annual revenues for the Company.
 
UltraMist revenues for Q4 2023 increased by more than 30% versus Q3 2023 and accounted for approximately 95% of the Company’s total revenues.
 
EDEN PRAIRIE, MN, January 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced that revenues for the fourth quarter of 2023 are expected to be in the range of $6.6 to $6.8 million, an increase of 20% to 24% over Q4 2022. Fiscal year 2023 revenues are expected to be in the range of $20.0 million to $20.2 million, an increase of 19% to 20% over the fiscal year ended 2022.
 
“Q4 2023 was a record quarter of revenue for SANUWAVE driven by strength in the UltraMist product line.  Consumables and in particular system sales saw accelerating growth as production constraints were overcome,” said CEO Morgan Frank.  “We’re extremely pleased to have shown this level of growth year on year up against what had previously been the best quarter in SANUWAVE history in Q4 2022 and look forward to carrying this success on into 2024.  The Company plans to release its full Q4 and annual results in late March and we look forward to speaking with you then to give you a more complete update on our quarterly and yearly performance and our future plans and guidance.”
 
The preliminary revenue results described herein are based on management’s initial analysis of the fourth quarter ended December 31, 2023, and may be subject to adjustments based on the Company’s completion of its year-end financial close process.
 
About SANUWAVE
 
SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
 
SANUWAVE’s end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. SANUWAVE applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
 
Forward-Looking Statements
 
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations and constraints, plans for future business development activities and the Company’s proposed business combination with SEP Acquisition Corp. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with the regulatory approval and marketing of the Company’s  products, supply chain and production constraints, regulatory oversight, the Company’s ability to manage its capital resource issues, competition, the Company’s ability to consummate the proposed business combination with SEP Acquisition Corp. and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
 
Contact: investors@sanuwave.com
 

 EX-101.SCH 3 snwv-20240110.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 snwv-20240110_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number No Trading Symbol Flag EX-101.PRE 5 snwv-20240110_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 image00001.jpg begin 644 image00001.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Jan. 10, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 10, 2024
Entity File Number 000-52985
Entity Registrant Name SANUWAVE Health, Inc.
Entity Central Index Key 0001417663
Entity Incorporation, State or Country Code NV
Entity Tax Identification Number 20-1176000
Entity Address, Address Line One 11495 Valley View Road
Entity Address, City or Town Eden Prairie
Entity Address, State or Province MN
Entity Address, Postal Zip Code 55344
City Area Code 770
Local Phone Number 419-7525
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
XML 8 ef20018511_8k_htm.xml IDEA: XBRL DOCUMENT 0001417663 2024-01-10 2024-01-10 false 0001417663 8-K 2024-01-10 SANUWAVE Health, Inc. NV 000-52985 20-1176000 11495 Valley View Road Eden Prairie MN 55344 770 419-7525 false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( +& *E@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "Q@"I8P*6ZC>X K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M2L0P$(=?17)O)\FJ8.CVHGA2$%Q0O(5D=C=L\X=DI-VWMZV[740?P&-F?OGF M&YC&)&5BQI<<$V9R6*X&WX6B3%JS/5%2 ,7LT>M2CXDP-KTWC,^\@:7/0 M.P3)^2UX)&TU:9B 55J(K&VL42:CIIA/>&L6?/K,W0RS!K!#CX$*B%H :Z>) MZ3AT#5P $XPP^_)=0+L0Y^J?V+D#[)0']^>IW7K5PH MI(/!\5=QBHX)U^P\^6UU_[!Y9*WD\KKBHA)\(X7B-TK>?4RN/_PNPCY:MW7_ MV/@LV#;PZR[:+U!+ P04 " "Q@"I8F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M +& *ECCLGO&Z@, ,D. 8 >&PO=V]R:W-H965T&UL MC9=M<]HX$,>_BL8WTU=);!GSE -F"$VNN3:4"6DRC10&RM%QF>:F$V:,KV[X5)M MAQ[UWA\\BM7:N@?^:)"S%9]S^RV?:>CYI4HB4IX9H3*B^7+HC>GU35@8%".> M!=^:HS9Q4UDH]=UU[I.A%S@B+GELG02#OU<^X5(Z)>#X<1#URF\ZP^/VN_I= M,7F8S((9/E'R121V/?1Z'DGXDFVD?53;3_PPH;;3BY4TQ2_9[L=&D4?BC;$J M/1@#02JR_3][.SCBR"!LG3 (#P9AP;W_4$'YD5DV&FBU)=J-!C77**9:6 .< MR-RJS*V&MP+L[.BCBC?@9$M8EI#;S J[(_?9?K7!:P/?PD?<4#\^"-[L!<,3 M@G^S[(K0X(*$01C];.X#6PD8EH!AH=N7 IUW.Z^!P\][E9P0B*B$B M5&4,!$E!<2?9JHX"MU\R:3C"T2XYVNL77*D,HZ8XZI1H M'53P$-MW0G(RW:0+KNN@<(T@""[;8;_71GBZ)4_W')Y'OA(NLL%G4Y;6.@K7 MF8^GWU[&S[?D$V?2KB]@]\97"%^OY.N=PS>!U=1,@FK"W\AGOJLCQ)7 :S2B MW4ZGA6#U2ZS^.5@P2:5SI8LD=4'F%H*,*$TF:@.\@*V26E_BXM-GA) &54H- MSF%\8F_D/@'_B:6("U D\!HDP^"2@@O!E1CA4=*GYQ".DP02HKEX;Y O,(Y\ MS6I=UR!):=1ODVG?BF@]3#*VJ"Q1/[+^BS92QL)O_$?G) M+=*@V&ZW(BP?TZI64#S%%\LXAJ/D:11UK^H&'PR6ZL,*PT- M(A'M7W;;(58::%4;Z%G%X3;E>B6R%?D+%.P:_)3F+*M-P0V"306>5F6!XMG\ M10MK80,!2[K)#HG-U"+A0HU(54F@>-J>*REB89VC'F#G:<%D+0^NTL035OD_ MQ)/U3//+&-S#8>OOCX9P.H-#[-?ELCZT&O0:R:J\'^))^C>R>V,V0-8(B,N> M!/2/+B;NDO? 7#P;(OD2A(*K+FQPO;\W[3M6Y<5=9:$LW'R*YAKNFER[ ?!^ MJ91][[CK3WE['?T/4$L#!!0 ( +& *EB?H!OPL0( .(, - >&PO M9KEMWDOSAR+DCO9*ZW="C<\W[)&D/ M1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O M:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\" MO @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9 MY=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:*Q[V_LL) MBS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W M3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y M]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5T MR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41P+ \& /,)WAA>?ZG_:S0_00, MX[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/ M+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^ M>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,/O'^8* \^>Q\ETWLJ.?]74_P$4$L#!!0 ( +& *EB7BKL

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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 1 19 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://sanuwave.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ef20018511_8k.htm snwv-20240110.xsd snwv-20240110_lab.xml snwv-20240110_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ef20018511_8k.htm": { "nsprefix": "snwv", "nsuri": "http://sanuwave.com/20240110", "dts": { "inline": { "local": [ "ef20018511_8k.htm" ] }, "schema": { "local": [ "snwv-20240110.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "labelLink": { "local": [ "snwv-20240110_lab.xml" ] }, "presentationLink": { "local": [ "snwv-20240110_pre.xml" ] } }, "keyStandard": 19, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 19 }, "report": { "R1": { "role": "http://sanuwave.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20240110to20240110", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20018511_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20240110to20240110", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "ef20018511_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r4" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://sanuwave.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001140361-24-001728-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-24-001728-xbrl.zip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end